succinylcholine has been researched along with Facial Hemiatrophy in 1 studies
Succinylcholine: A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.
succinylcholine : A quaternary ammonium ion that is the bis-choline ester of succinic acid.
Facial Hemiatrophy: A syndrome characterized by slowly progressive unilateral atrophy of facial subcutaneous fat, muscle tissue, skin, cartilage, and bone. The condition typically progresses over a period of 2-10 years and then stabilizes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tritakarn, T | 1 |
| Teeratchanan, T | 1 |
1 other study available for succinylcholine and Facial Hemiatrophy
| Article | Year |
|---|---|
Acute rhabdomyolysis and cardiac arrest following succinylcholine in a patient with Parry-Romberg syndrome.
Topics: Acute Disease; Adolescent; Amiodarone; Anti-Arrhythmia Agents; Calcium Gluconate; Cardiopulmonary Re | 2011 |